Skip to main content

Table 2 Differences in the clinical characteristics of group 1 (hyperechoic) and group 2 (hypoechoic) determined by CDUS

From: An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity

 

Group 1 (n = 28)

Group 2 (n = 18)

P-value

Age (years), mean ± SD

62.22 ± 6.31

62.96 ± 9.54

0.456

Men, n (%)

26 (92.9%)

17 (94.4%)

1.000

Neurological symptoms*, n (%)

16 (57.1%)

8 (44.4%)

0.295

Hypertension, n (%)

17 (60.7%)

10 (55.6%)

0.767

Diabetes mellitus, n (%)

8 (28.5%)

5 (27.8%)

1.000

Hypercholesterolemia, n (%)

15 (53.6%)

12 (66.7%)

0.541

Current smoker, n (%)

18 (64.3%)

13 (72.2%)

0.749

  1. *Neurological symptoms include previous transient ischemic attacks (TIA), dysphasia, single limb paresis, and amaurosis fugax.